Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT01230047
Other study ID # 1018
Secondary ID
Status Active, not recruiting
Phase N/A
First received October 19, 2010
Last updated October 27, 2010
Start date October 2010
Est. completion date October 2011

Study information

Verified date October 2010
Source Arizona State University
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

This is a quasi-experimental evaluation of psychoeducational course focusing on mindfulness and lifestyle changes for depression and anxiety; clients in active treatment group are compared to those in a treatment-as-usual wait-list control group. The primary hypothesis is that the psychoeducational course will result in lower levels of depression and anxiety as compared to the wait-listed treatment-as-usual comparison group.


Description:

This study evaluates a psychoeducational intervention: Teaching mindfulness and lifestyle interventions to adult clients who self-report problems with depression and/or anxiety. The course is eight weeks long. Clients are assigned to either (1) receive the course (COU condition) from October- December 2010 or (2) placed on a waiting list and receive treatment-as-usual (TAU condition). Those in the TAU group will be offered the course in January 2011.

Random assignment to COU or TAU conditions will be attempted although this may be relaxed due to institutional constraints.

Participants are assessed on the Beck Depression Inventory (BDI) and Beck Anxiety Inventory (BAI) at the beginning of the course, on the last day of the course, at 1-month post-course, at 4-months post-course, and at 12-months post-course.

Participants in the COU condition will be compared to those in TAU condition at the beginning of the course, on the last day of the course, and at 1-month post-course. Further evaluations (4 and 12 months post-course) will be pre-post evaluations without a comparison group.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 30
Est. completion date October 2011
Est. primary completion date January 2011
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria:

- Participants self-report as having depression or anxiety

- Adults (age 18 or above)

- Clients willing to participate in an 8-week psychoeducational course

Exclusion Criteria:

- A diagnosis of a psychotic disorder

- Unwilling to participate in 8-week psychoeducational course

Study Design

Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Intervention

Behavioral:
Psychoeducational course
Psychoeducational course on mindfulness and lifestyle interventions for depression and anxiety

Locations

Country Name City State
United States Utah Youth Village Salt Lake City Utah

Sponsors (1)

Lead Sponsor Collaborator
Arizona State University

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Beck Depression Inventory (BDI) Depression will be assessed by comparing BDI scores on day one with BDI scores at twelve weeks (four weeks after conclusion of the psychoeducational course).
The primary study hypothesis is that the psychoeducational course group will have a greater reduction in BDI scores when compared to the treatment-as-usual wait-listed comparison group.
BDI administered at 12 weeks No
Secondary Beck Anxiety Inventory (BAI) BAI administered at 8 weeks No
Secondary Beck Anxiety Inventory (BAI) BAI administered at 12 weeks No
Secondary Beck Anxiety Inventory (BAI) BAI administered at 24 weeks No
Secondary Beck Anxiety Inventory (BAI) BAI administered at 60 weeks No
Secondary Beck Depression Inventory (BDI) BDI administered at 8 weeks No
Secondary Beck Depression Inventory (BDI) BDI administered at 24 weeks No
Secondary Beck Depression Inventory (BDI) BDI administered at 60 weeks No
Secondary Beck Anxiety Inventory (BAI) BAI administered at Day 1 of Study No
Secondary Beck Depression Inventory (BDI) BDI administered at Day 1 of Study No
Secondary Client Medication Use Clients fill out a survey which includes a question asking if they are currently taking psychiatric medication. Measured on Day 1 of Study No
Secondary Client Medication Use Clients fill out a survey which includes a question asking if they are currently taking psychiatric medication. Measured at 8 weeks No
Secondary Client Medication Use Clients fill out a survey which includes a question asking if they are currently taking psychiatric medication. Measured at 12 weeks No
Secondary Client Medication Use Clients fill out a survey which includes a question asking if they are currently taking psychiatric medication. Measured at 24 weeks No
Secondary Client Medication Use Clients fill out a survey which includes a question asking if they are currently taking psychiatric medication. Measured at 60 weeks No
Secondary Client Currently Seeing Therapist Clients are given a survey which includes a question asking if they are currently seeing a clinician for psychotherapy. Measured on Day 1 of study No
Secondary Client Currently Seeing Therapist Clients are given a survey which includes a question asking if they are currently seeing a clinician for psychotherapy. Measured at week 8 No
Secondary Client Currently Seeing Therapist Clients are given a survey which includes a question asking if they are currently seeing a clinician for psychotherapy. Measured at week 12 No
Secondary Client Currently Seeing Therapist Clients are given a survey which includes a question asking if they are currently seeing a clinician for psychotherapy. Measured at week 24 No
Secondary Client Currently Seeing Therapist Clients are given a survey which includes a question asking if they are currently seeing a clinician for psychotherapy. Measured at week 60 No
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05777044 - The Effect of Hatha Yoga on Mental Health N/A
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Recruiting NCT04977232 - Adjunctive Game Intervention for Anhedonia in MDD Patients N/A
Recruiting NCT04043052 - Mobile Technologies and Post-stroke Depression N/A
Completed NCT04512768 - Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy N/A
Recruiting NCT03207828 - Testing Interventions for Patients With Fibromyalgia and Depression N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Completed NCT04476446 - An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives Phase 3
Recruiting NCT02783430 - Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease Phase 2/Phase 3
Recruiting NCT05563805 - Exploring Virtual Reality Adventure Training Exergaming N/A
Completed NCT04598165 - Mobile WACh NEO: Mobile Solutions for Neonatal Health and Maternal Support N/A
Completed NCT03457714 - Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
Recruiting NCT05956912 - Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
Completed NCT05588622 - Meru Health Program for Cancer Patients With Depression and Anxiety N/A
Recruiting NCT05234476 - Behavioral Activation Plus Savoring for University Students N/A
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Enrolling by invitation NCT03276585 - Night in Japan Home Sleep Monitoring Study
Terminated NCT03275571 - HIV, Computerized Depression Therapy & Cognition N/A
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A